1 |
100 µg brimonidine tartrate implant |
Brimonidine |
2件: D02076 D02076, D07540 D07540 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
090 1件: 90 💬 |
2 |
200 µg brimonidine tartrate implant |
Brimonidine |
2件: D02076 D02076, D07540 D07540 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
090 1件: 90 💬 |
3 |
400 µg brimonidine tartrate implant |
Brimonidine |
2件: D02076 D02076, D07540 D07540 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
090 1件: 90 💬 |
4 |
Brimonidine |
Brimonidine |
2件: D02076 D02076, D07540 D07540 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 2件: 13, 90 💬 |
5 |
Brimonidine tartrate |
Brimonidine |
2件: D02076 D02076, D07540 D07540 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 2件: 13, 90 💬 |
6 |
Brimonidine tartrate posterior segment drug delivery system (brimo ps dds) applicator system |
Brimonidine |
2件: D02076 D02076, D07540 D07540 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
090 1件: 90 💬 |